Advertisement Greyson International granted notice of allowance for Trilexon - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Greyson International granted notice of allowance for Trilexon

Greyson International, a developer and marketer of health and beauty aid products, has received a notice of allowance from the US Patent and Trademark Office for Trilexon, a delivery system designed to improve effectiveness of skin-care, hair-care and other topical applications.

Greyson intends to enter the royalty division of business and effectively license Trilexon to clients in the drug, cosmetic and toiletry industries, upon which Greyson will retain a percentage of sales from products utilizing the Trilexon delivery system.

Harvey Tauman, president and CEO of Greyson, said: “We highly anticipate the introduction of Trilexon as a new delivery method to improve effectiveness of virtually every topical application on a worldwide level.”